Domenico Ribatti
University of Bari
965 Papers
6.1K Citations
Domenico Ribatti is an academic researcher from University of Bari. The author has contributed to research in topics: Angiogenesis & Biology. The author has an hindex of 96, co-authored 913 publications. Previous affiliations of Domenico Ribatti include University of Genoa & National Institutes of Health.
Chat about Author
Papers
Use of the Stromal Vascular Fraction in Intermediate-Deep Acute Burns: A Case With Its Own Control
Giuseppe Giudice,Angela Filoni,Giulio Maggio,Domenico Bonamonte,Michele Maruccia,Eleonora Nacchiero,Domenico Ribatti,Tiziana Annese,Michelangelo Vestita +8 more
TL;DR: SVF could potentially represent a valid alternative to the current standard of care, with a decreased need of invasive surgery and consequent improved patients' quality of life.
In vitro and ex vivo retina angiogenesis assays
Sara Rezzola,Mirella Belleri,Giuseppina Gariano,Domenico Ribatti,Domenico Ribatti,Ciro Costagliola,Francesco Semeraro,Marco Presta +7 more
TL;DR: In vitro and ex vivo angiogenesis assays may be suitable for a rapid screening of potential anti-angiogenic molecules before in vivo validation of the putative lead compounds, and recent observations have shown that eye neovascularization in zebrafish embryos, an in vivo animal platform experimentally analogous to in vitro/ex vivo models, may represent a novel target for the identification of angiogenic inhibitors.
Hydrogels for biomedical applications from glycol chitosan and PEG diglycidyl ether exhibit pro-angiogenic and antibacterial activity
Giuseppe Tripodo,Adriana Trapani,Antonio Rosato,C. Di Franco,Roberto Tamma,Giuseppe Trapani,Domenico Ribatti,Delia Mandracchia +7 more
TL;DR: In-vivo study using the chick embryo choriallantoic membrane resulted in a highly pronounced pro-angiogenic activity suggesting important tissue regeneration properties and GCS-PEG scaffolds displayed a significant antimicrobial activity against Staphylococcus aureus.
Docetaxel versus paclitaxel for antiangiogenesis.
Angelo Vacca,Domenico Ribatti,Monica Iurlaro,Francesca Merchionne,Beatrice Nico,Roberto Ria,Franco Dammacco +6 more
TL;DR: It is suggested that very low docetaxel and paclitaxel doses selectively cause organic and functional damage of endothelial cells and that docetAXel is four times stronger than usual and could be applied to treat Kaposi's sarcoma and cancers.
Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells.
Antonio Pellegrino,Roberto Ria,Giulia Di Pietro,Teresa Cirulli,Giammarco Surico,Angela Pennisi,Fortunato Morabito,Domenico Ribatti,Angelo Vacca +8 more
TL;DR: Bone marrow endothelial cells (EC) from patients with multiple myeloma (MM) were found to express and secrete higher amounts of the CXC‐chemokines CXCL8/interleukin (IL)‐8, C XCL11/interferon‐inducible T‐cell alpha chemoattractant (I‐TAC), CxCL12/stromal cell‐derived factor (SDF)‐1α, and C